Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.43 | -$0.29 | -$0.36 |
| Q2 2025 | 3 | -$0.31 | -$0.29 | -$0.30 |
| Q3 2025 | 2 | -$0.27 | -$0.21 | -$0.24 |
| Q4 2025 | 1 | -$0.27 | -$0.21 | -$0.24 |
| Q1 2026 | 2 | -$0.27 | -$0.22 | -$0.25 |
| Q2 2026 | 1 | -$0.34 | -$0.30 | -$0.32 |
| Q3 2026 | 1 | -$0.27 | -$0.25 | -$0.26 |
| Q4 2026 | 1 | -$0.27 | -$0.25 | -$0.26 |
Envoy Medical, Inc. last posted its earnings results on Monday, November 10th, 2025. The company reported $-0.35 earnings per share for the quarter, missing analysts' consensus estimates of $-0.27 by $0.08. The company had revenue of 42.00 K for the quarter and had revenue of 225.00 K for the year. Envoy Medical, Inc. has generated $-1 earnings per share over the last year ($-1.49 diluted earnings per share) and currently has a price-to-earnings ratio of -0.76. Envoy Medical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 27th, 2026 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/10/2025 | Q3 2025 | -$0.27 | -$0.35 | -0.08 | $60.00 K | $42.00 K |
| 07/31/2025 | Q2 2025 | -$0.29 | -$0.32 | -0.03 | $66.25 K | $78.00 K |
| 05/01/2025 | Q1 2025 | -$0.35 | -$0.29 | 0.06 | N/A | $46.00 K |
| 03/28/2025 | Q4 2024 | N/A | -$0.36 | N/A | N/A | $42.00 K |
| 11/14/2024 | Q3 2024 | -$0.27 | -$0.37 | -0.1 | $75.00 K | $56.00 K |
| 08/12/2024 | Q2 2024 | -$0.24 | -$0.27 | -0.03 | $82.50 K | $68.00 K |
| 03/31/2024 | Q1 2024 | N/A | -$0.41 | N/A | N/A | $59.00 K |
| 12/29/2023 | Q4 2023 | N/A | -$0.25 | N/A | N/A | $95.00 K |
| 09/29/2023 | Q3 2023 | N/A | $0.07 | N/A | N/A | $80.00 K |
| 06/29/2023 | Q2 2023 | N/A | -$0.68 | N/A | N/A | $63.00 K |
| 05/15/2023 | Q1 2023 | N/A | -$1.30 | N/A | N/A | $78.00 K |
| 12/30/2022 | Q4 2022 | N/A | -$0.22 | N/A | N/A | $20.00 K |
| 11/14/2022 | Q3 2022 | N/A | -$0.13 | N/A | N/A | $57.00 K |
| 08/15/2022 | Q2 2022 | N/A | -$0.17 | N/A | N/A | $59.00 K |
| 05/16/2022 | Q1 2022 | N/A | $0.23 | N/A | N/A | $101.00 K |
| 03/31/2022 | Q4 2021 | N/A | -$0.09 | N/A | N/A | $0 |
| 12/30/2021 | Q3 2021 | N/A | $0.10 | N/A | N/A | $0 |
| 08/17/2021 | Q2 2021 | N/A | $0.01 | N/A | N/A | $0 |
| 05/17/2021 | Q1 2021 | N/A | -$0.04 | N/A | N/A | $0 |
| 12/30/2020 | Q4 2020 | N/A | -$0.00 | N/A | N/A | $0 |
Envoy Medical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 27th, 2026 based offlast year's report dates.
The conference call for Envoy Medical, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Envoy Medical, Inc.'s latest earnings report can be read online.
Envoy Medical, Inc. (:COCH) has a recorded annual revenue of $225.00 K.
Envoy Medical, Inc. (:COCH) has a recorded net income of $-20,795,000.Envoy Medical, Inc. has generated $-1.49 earnings per share over the last four quarters.
Envoy Medical, Inc. (:COCH) has a price-to-earnings ratio of -0.76 and price/earnings-to-growth ratio is -0.51.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED